Clinical Manifestations and Treatment Outcomes of Pyoderma Gangrenosum on Rituximab Therapy: A Systematic Review - Supplemental Material

Supplemental material for 'Clinical Manifestations and Treatment Outcomes of Pyoderma Gangrenosum on Rituximab Therapy: A Systematic Review'. Each file corresponds to a supplementary table referenced within the article text.

Supplementary 1. Probability assessment of rituximab-induced PG based on the Adverse Drug Reaction Probability Scale by Naranjo et al.

Supplementary 2. List of included articles and contributory number of cases.

本资料为《利妥昔单抗（Rituximab）治疗下坏疽性脓皮病（Pyoderma Gangrenosum，PG）的临床表现与治疗转归：一项系统综述》的补充材料。每份文件对应正文中引用的补充表格。
补充材料1：基于纳兰霍（Naranjo）等人提出的药物不良反应概率量表（Adverse Drug Reaction Probability Scale）的利妥昔单抗诱导坏疽性脓皮病概率评估。
补充材料2：纳入文献列表及各文献贡献的病例数。